Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy

The most common form of heart failure occurs with normal systolic function and often involves cardiac hypertrophy in the elderly. To clarify the biological mechanisms that drive cardiac hypertrophy in aging, we tested the influence of circulating factors using heterochronic parabiosis, a surgical technique in which joining of animals of different ages leads to a shared circulation. After 4 weeks of exposure to the circulation of young mice, cardiac hypertrophy in old mice dramatically regressed, accompanied by reduced cardiomyocyte size and molecular remodeling. Reversal of age-related hypertrophy was not attributable to hemodynamic or behavioral effects of parabiosis, implicating a blood-borne factor. Using modified aptamer-based proteomics, we identified the TGF-β superfamily member GDF11 as a circulating factor in young mice that declines with age. Treatment of old mice to restore GDF11 to youthful levels recapitulated the effects of parabiosis and reversed age-related hypertrophy, revealing a therapeutic opportunity for cardiac aging.

[1]  T. Jessell,et al.  Assigning the Positional Identity of Spinal Motor Neurons Rostrocaudal Patterning of Hox-c Expression by FGFs, Gdf11, and Retinoids , 2001, Neuron.

[2]  D. Kitzman.  Diastolic Heart Failure in the Elderly , 2004, Heart Failure Reviews.

[3]  A. Mcpherron.  METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11. , 2010, Immunology, endocrine & metabolic agents in medicinal chemistry.

[4]  Melissa F. Jackson,et al.  The aging myostatin null phenotype: reduced adiposity, cardiac hypertrophy, enhanced cardiac stress response, and sexual dimorphism. , 2012, The Journal of endocrinology.

[5]  S. Cook,et al.  Transcriptional Effects of Chronic Akt Activation in the Heart* , 2002, The Journal of Biological Chemistry.

[6]  Richard T. Lee,et al.  Interleukin-33 Prevents Apoptosis and Improves Survival After Experimental Myocardial Infarction Through ST2 Signaling , 2009, Circulation. Heart failure.

[7]  A. Joyner,et al.  Expression of growth/differentiation factor 11, a new member of the BMP/TGFβ superfamily during mouse embryogenesis , 1999, Mechanisms of Development.

[8]  T. Abraham,et al.  Myostatin does not regulate cardiac hypertrophy or fibrosis , 2007, Neuromuscular Disorders.

[9]  Xueying Gu,et al.  GDF11 modulates NGN3+ islet progenitor cell number and promotes β-cell differentiation in pancreas development , 2004, Development.

[10]  D. Lacey,et al.  Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival , 2010, Cell.

[11]  Daniel Levy,et al.  Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. , 2003, Circulation.

[12]  K. Matthews,et al.  Myostatin, a transforming growth factor‐β superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct , 1999, Journal of cellular physiology.

[13]  P. Anversa,et al.  Gender differences and aging: effects on the human heart. , 1995, Journal of the American College of Cardiology.

[14]  S. Brachat,et al.  Blockade of the Activin Receptor IIB Activates Functional Brown Adipogenesis and Thermogenesis by Inducing Mitochondrial Oxidative Metabolism , 2012, Molecular and Cellular Biology.

[15]  K. Eggan,et al.  Ovulated oocytes in adult mice derive from non-circulating germ cells , 2006, Nature.

[16]  R. Franklin,et al.  Rejuvenation of regeneration in the aging central nervous system. , 2012, Cell stem cell.

[17]  J. C. Finerty.  Parabiosis in physiological studies. , 1952, Physiological reviews.

[18]  M. Matzuk,et al.  GDF11 Controls the Timing of Progenitor Cell Competence in Developing Retina , 2005, Science.

[19]  M. Matzuk,et al.  Regulation of muscle growth by multiple ligands signaling through activin type II receptors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  I. Weissman,et al.  Little Evidence for Developmental Plasticity of Adult Hematopoietic Stem Cells , 2002, Science.

[21]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[22]  D. Levy,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[23]  Se-Jin Lee,et al.  Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11 , 1999, Nature Genetics.

[24]  T. Zimmers,et al.  Induction of Cachexia in Mice by Systemically Administered Myostatin , 2002, Science.

[25]  I. Weissman,et al.  Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium , 2004, Nature.

[26]  E. Lakatta,et al.  Use of tibial length to quantify cardiac hypertrophy: application in the aging rat. , 1982, The American journal of physiology.

[27]  J. Hodgin,et al.  A noninvasive computerized tail-cuff system for measuring blood pressure in mice. , 1995, Hypertension.

[28]  Knut Mai,et al.  Sex differences in physiological cardiac hypertrophy are associated with exercise-mediated changes in energy substrate availability. , 2011, American journal of physiology. Heart and circulatory physiology.

[29]  R. Graham,et al.  Cardiac α1-adrenergic drive in pathological remodelling , 2007 .

[30]  K. Patel,et al.  Developmental expression of myostatin in cardiomyocytes and its effect on foetal and neonatal rat cardiomyocyte proliferation. , 2007, Cardiovascular research.

[31]  R. Kloner,et al.  Alterations in myostatin expression are associated with changes in cardiac left ventricular mass but not ejection fraction in the mouse. , 2007, The Journal of endocrinology.

[32]  A. Wagers,et al.  Improved cutaneous healing in diabetic mice exposed to healthy peripheral circulation. , 2009, The Journal of investigative dermatology.

[33]  Xuan Chen,et al.  Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators. , 2008, Molecular endocrinology.

[34]  D. Greenspan,et al.  GDF11 Forms a Bone Morphogenetic Protein 1-Activated Latent Complex That Can Modulate Nerve Growth Factor-Induced Differentiation of PC12 Cells , 2005, Molecular and Cellular Biology.

[35]  J. Nickel,et al.  Promiscuity and specificity in BMP receptor activation , 2012, FEBS letters.

[36]  K. Shyu,et al.  Myostatin expression in ventricular myocardium in a rat model of volume‐overload heart failure , 2006, European journal of clinical investigation.

[37]  I. Weissman,et al.  Isolation of Adult Mouse Myogenic Progenitors Functional Heterogeneity of Cells within and Engrafting Skeletal Muscle , 2004, Cell.

[38]  G. Aurigemma.  Diastolic heart failure--a common and lethal condition by any name. , 2006, The New England journal of medicine.

[39]  Marco Sandri,et al.  Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.

[40]  M. Redfield,et al.  Epidemiology of diastolic heart failure. , 2005, Progress in cardiovascular diseases.

[41]  C. Murry,et al.  Myostatin represses physiological hypertrophy of the heart and excitation–contraction coupling , 2009, The Journal of physiology.

[42]  P. Serup,et al.  Analysis of pancreatic endocrine development in GDF11‐deficient mice , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[43]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[44]  T. Rando,et al.  Heterochronic parabiosis for the study of the effects of aging on stem cells and their niches , 2012, Cell cycle.

[45]  M. Zile,et al.  β3 Integrin‐mediated ubiquitination activates survival signaling during myocardial hypertrophy , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  J. Kaye,et al.  The aging systemic milieu negatively regulates neurogenesis and cognitive function , 2011, Nature.

[47]  M. MacCoss,et al.  Overexpression of Catalase Targeted to Mitochondria Attenuates Murine Cardiac Aging , 2009, Circulation.

[48]  Da-Zhi Wang,et al.  Loss of mXinalpha, an intercalated disk protein, results in cardiac hypertrophy and cardiomyopathy with conduction defects. , 2007, American journal of physiology. Heart and circulatory physiology.

[49]  R. Gerszten,et al.  Targeted Metabolomics , 2012, Current protocols in molecular biology.

[50]  Richard T. Lee,et al.  Targeted Deletion of Thioredoxin-Interacting Protein Regulates Cardiac Dysfunction in Response to Pressure Overload , 2007, Circulation research.

[51]  Y. Dor,et al.  Systemic Regulation of the Age-Related Decline of Pancreatic β-Cell Replication , 2013, Diabetes.

[52]  K. Tsuchida,et al.  Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer. , 2008, Endocrine journal.

[53]  G. Schuler,et al.  Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model , 2009, European journal of heart failure.

[54]  I. Weissman,et al.  Rejuvenation of aged progenitor cells by exposure to a young systemic environment , 2005, Nature.

[55]  Tracy R. Keeney,et al.  Aptamer-based multiplexed proteomic technology for biomarker discovery , 2010, Nature Precedings.

[56]  Irving L. Weissman,et al.  Physiological Migration of Hematopoietic Stem and Progenitor Cells , 2001, Science.

[57]  C. Keller,et al.  Increased Wnt Signaling During Aging Alters Muscle Stem Cell Fate and Increases Fibrosis , 2007, Science.

[58]  Se-Jin Lee,et al.  Redundancy of myostatin and growth/differentiation factor 11 function , 2009, BMC Developmental Biology.

[59]  R. K. Meyer,et al.  An improved method of parabiosis , 1933 .

[60]  J. Molkentin,et al.  Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting. , 2011, American journal of physiology. Heart and circulatory physiology.

[61]  V. Rosen,et al.  A novel BMP expressed in developing mouse limb, spinal cord, and tail bud is a potent mesoderm inducer in Xenopus embryos. , 1999, Developmental biology.